Results 131 to 140 of about 699,568 (298)

Asymptotic properties of cross‐classified sampling designs

Canadian Journal of Statistics, EarlyView.
Abstract We investigate the family of cross‐classified sampling designs across an arbitrary number of dimensions. We introduce a variance decomposition that enables the derivation of general asymptotic properties for these designs and the development of straightforward and asymptotically unbiased variance estimators.
Jean Rubin, Guillaume Chauvet
wiley   +1 more source

Blood Transfusion: a new, international scientific journal for Transfusion Medicine.

, 2008
Claudio Velati
openalex   +1 more source

Body iron status of children and adolescents with transfusion dependent β-thalassaemia: trends of serum ferritin and associations of optimal body iron control [PDF]

, 2018
Tharindi Suriapperuma, Ravindu Peiris, Chamila Mettananda, Anuja Premawardhena, Sachith Mettananda   +4 more
openalex   +1 more source

Population Pharmacokinetics and Exposure–Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis

Clinical Pharmacology &Therapeutics, EarlyView.
Momelotinib, a Janus kinase (JAK) 1/JAK2/activin A receptor type 1 inhibitor, is approved for the treatment of myelofibrosis with anemia. These analyses characterized the population pharmacokinetics of momelotinib and its active metabolite M21 following administration of the commercial tablet formulation in patients with myelofibrosis from phase II/III
Benjamin Rich, Meenakshi Srinivasan, Yu Liu Ho, Sandra A.G. Visser, Geraldine Ferron‐Brady, Georgios Vlasakakis   +5 more
wiley   +1 more source

Came as a blood donor and ended up being transfused: an example of “what not to do” [PDF]

José Antonio García‐Erce, Alicia Aranguren Azparren   +1 more
openalex   +1 more source

Mesenteric Vein Thrombosis Following Platelet Transfusion in a Patient with Hemorrhagic Fever with Renal Syndrome: A Case Report [PDF]

, 2018
Anne‐Marie Fors Connolly, Johan Rasmuson, Mikael Öman, Clas Ahlm   +3 more
openalex   +1 more source

Not as “D”eadly as once thought – the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma [PDF]

, 2023
Mark H. Yazer, Gleb Panko, John B. Holcomb, Alesia Kaplan, Christine M. Leeper, Jansen N. Seheult, Darrell J. Triulzi, Philip C. Spinella   +7 more
openalex   +1 more source

Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens

Clinical Pharmacology &Therapeutics, EarlyView.
Real‐world edoxaban concentrations in older patients receiving reduced‐dose regimens. Low trough concentrations (< 12 ng/mL) were associated with an increased risk of thromboembolism. Among patients meeting the ELDERCARE‐AF criteria, low drug levels were more frequent with the 15 mg regimen than with the 30 mg regimen.
Sung‐Chun Tang, Shin‐Yi Lin, Chih‐Hao Chen, Yen‐Bin Liu, Li‐Ting Ho, Ching‐Hua Kuo, Yu‐Fong Peng, Chih‐Fen Huang, Jiann‐Shing Jeng   +8 more
wiley   +1 more source

Is autologous cord blood transfusion effective and safe in preterm infants? [PDF]

, 2017
Beril Altaş Yavuz, Emel Okulu, Saadet Arsan, İlke Mungan Akın, Begüm Atasay, Ömer Erdeve   +5 more
openalex   +1 more source

Low Rate of RBC Alloimmunization Among Transfused Children with Sickle Cell Anemia in Malawi Without Pre-Transfusion Screening or Antigen Matching [PDF]

April Evans, Kristina Prus, Apatsa Matatiyo, Gugulethu Mapurisa, Memory Nonganonga, Manley Kamija, Kambe Banda-Zgambo, Timothy Mutafya, Meffa Misiri, Rizine Mzikamanda, Katherine D. Westmoreland, Russell E. Ware   +11 more
openalex   +1 more source